Maccura Biotechnology Co Ltd
SZSE:300463
Maccura Biotechnology Co Ltd
Cash from Financing Activities
Maccura Biotechnology Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Maccura Biotechnology Co Ltd
SZSE:300463
|
Cash from Financing Activities
-¥143.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Cash from Financing Activities
-¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Cash from Financing Activities
¥3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Cash from Financing Activities
-¥2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Cash from Financing Activities
-¥7.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Genscript Biotech Corp
HKEX:1548
|
Cash from Financing Activities
$1.4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
See Also
What is Maccura Biotechnology Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-143.1m
CNY
Based on the financial report for Sep 30, 2023, Maccura Biotechnology Co Ltd's Cash from Financing Activities amounts to -143.1m CNY.
What is Maccura Biotechnology Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
10%
The average annual Cash from Financing Activities growth rates for Maccura Biotechnology Co Ltd have been 10% over the past three years .